Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.835 USD | -0.15% | +1.91% | +35.19% |
May. 07 | AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast | MT |
May. 07 | Transcript : AdaptHealth Corp., Q1 2024 Earnings Call, May 07, 2024 |
Summary
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- Low profitability weakens the company.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+35.19% | 1.27B | D+ | ||
-5.39% | 182B | C+ | ||
+3.87% | 114B | C | ||
-3.38% | 68.38B | A | ||
+6.06% | 52.46B | B- | ||
+8.16% | 44.25B | B- | ||
+7.52% | 43.55B | B+ | ||
+25.13% | 32.69B | B | ||
+17.85% | 26.73B | A- | ||
-0.65% | 25.79B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AHCO Stock
- Ratings AdaptHealth Corp.